PROTEINURIA
Clinical trials for PROTEINURIA explained in plain language.
Never miss a new study
Get alerted when new PROTEINURIA trials appear
Sign up with your email to follow new studies for PROTEINURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to slow kidney disease in IgA patients
Disease control Recruiting nowThis study tests whether combining budesonide and ambrisentan can lower protein in the urine and slow kidney function loss in people with IgA nephropathy, a chronic kidney disease. About 129 adults aged 18–70 with protein in their urine will receive the combo for 36 weeks. The go…
Matched conditions: PROTEINURIA
Phase: PHASE4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
New hope for kids with kidney disease: finerenone safety trial launches
Disease control Recruiting nowThis study looks at the long-term safety of adding finerenone to standard blood pressure medicines for children aged 1 to 18 with chronic kidney disease and protein in their urine. About 100 participants who were in a previous finerenone study will take the drug for up to 18 mont…
Matched conditions: PROTEINURIA
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
New hope for kids with kidney disease: drug combo may cut protein leak
Disease control Recruiting nowThis study tests whether adding finerenone to standard blood pressure medicines can reduce protein in the urine of children with chronic kidney disease. About 219 children aged 6 months to under 18 years will take either finerenone or a placebo for 6 months. The goal is to see if…
Matched conditions: PROTEINURIA
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
New hope for transplant patients: drug targets protein spill in kidneys
Disease control Recruiting nowThis study tests a drug called sparsentan in 20 adults who have had a kidney transplant and still have protein in their urine due to IgA nephropathy or FSGS. The goal is to see if the drug can safely reduce protein levels over 36 weeks. Participants take one pill daily, and the s…
Matched conditions: PROTEINURIA
Phase: PHASE4 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 06:46 UTC
-
New combo therapy aims to calm overactive immune system in kidney disease
Disease control Recruiting nowThis study is testing whether combining two immune-suppressing drugs, rituximab and cyclosporine, can safely and effectively treat membranous nephropathy, a kidney disease where the immune system attacks the kidneys, causing protein to leak into urine. About 30 adults with persis…
Matched conditions: PROTEINURIA
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
App aims to improve kidney care for young adults
Knowledge-focused Recruiting nowThis study tests whether a smartphone app can help doctors and young adults (ages 16-29) with chronic kidney disease follow the latest treatment guidelines. The app provides reminders, education, and care recommendations. Researchers will check if using the app leads to better bl…
Matched conditions: PROTEINURIA
Phase: NA • Sponsor: St. James's Hospital, Ireland • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Scientists hunt for clues behind Post-Transplant protein leak
Knowledge-focused Recruiting nowThis study looks at why some people who get a new kidney start leaking protein in their urine again soon after the transplant. It focuses on patients with a kidney disease called FSGS. Researchers will test blood and kidney tissue samples before and after the transplant to find t…
Matched conditions: PROTEINURIA
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC
-
New study seeks clues to why kids get high blood pressure
Knowledge-focused Recruiting nowThis study looks at how certain natural chemicals in the body, like angiotensin-(1-7), affect high blood pressure and damage to the heart and kidneys in children. Researchers will follow 125 children with newly diagnosed high blood pressure and healthy kids for two years, collect…
Matched conditions: PROTEINURIA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC